Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RETA
2901
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.61M | ﹤0.01% |
35,400
+8,900
| +34% | +$842K |
|
2902
First Financial Corp
THFF
$942M
| $3.61M | ﹤0.01% |
111,089
-60,291
| -35% | -$2.06M |
|
2903
PUT
Norfolk Southern
NSC
$78.3B
| $3.61M | ﹤0.01% |
15,900
-30,000
| -65% | -$6.37M |
|
2904
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $3.6M | ﹤0.01% |
41,650
-136,245
| -77% | -$11.6M |
|
2905
Beyond Air
XAIR
$4.41M
| $3.6M | ﹤0.01% |
2,112
+1,561
| +283% | +$3.57M |
|
2906
Vanguard FTSE Emerging Markets ETF
VWO
$127B
| $3.59M | ﹤0.01% |
+88,263
| New | +$3.56M |
|
|
UTAA
2907
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
| $3.59M | ﹤0.01% |
340,000
| – | – |
|
2908
Amalgamated Financial
AMAL
$1.46B
| $3.59M | ﹤0.01% |
+222,839
| New | +$3.58M |
|
2909
Oil-Dri
ODC
$1.33B
| $3.59M | ﹤0.01% |
121,560
-60,344
| -33% | -$1.34M |
|
2910
Ternium
TX
$10.8B
| $3.57M | ﹤0.01% |
89,991
-188,275
| -68% | -$7.59M |
|
2911
CALL
Regions Financial
RF
$25.8B
| $3.56M | ﹤0.01% |
200,000
-130,100
| -39% | -$2.3M |
|
2912
El Pollo Loco
LOCO
$466M
| $3.56M | ﹤0.01% |
406,277
+46,100
| +13% | +$432K |
|
2913
Rocket Pharmaceuticals
RCKT
$424M
| $3.56M | ﹤0.01% |
+179,216
| New | +$3.62M |
|
2914
Alpha Teknova
TKNO
$382M
| $3.55M | ﹤0.01% |
1,330,741
+81,654
| +7% | +$219K |
|
|
ABST
2915
DELISTED
Absolute Software Corp
ABST
| $3.54M | ﹤0.01% |
309,273
+279,960
| +955% | +$2.8M |
|
2916
Stratasys
SSYS
$678M
| $3.54M | ﹤0.01% |
199,287
-181,631
| -48% | -$2.84M |
|
2917
Ranpak Holdings
PACK
$420M
| $3.53M | ﹤0.01% |
+782,022
| New | +$3.11M |
|
2918
Sana Biotechnology
SANA
$1.18B
| $3.53M | ﹤0.01% |
592,345
+258,458
| +77% | +$1.49M |
|
2919
Artivion
AORT
$1.31B
| $3.53M | ﹤0.01% |
205,336
-165,391
| -45% | -$2.44M |
|
|
USX
2920
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $3.52M | ﹤0.01% |
574,003
+83,965
| +17% | +$508K |
|
2921
Lennox International
LII
$13.6B
| $3.52M | ﹤0.01% |
10,801
-19,410
| -64% | -$5.49M |
|
|
ELEV
2922
DELISTED
Elevation Oncology
ELEV
| $3.52M | ﹤0.01% |
+2,316,426
| New | +$6.11M |
|
|
MNTN
2923
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
| $3.51M | ﹤0.01% |
330,000
| – | – |
|
2924
CALL
Quest Diagnostics
DGX
$26.8B
| $3.51M | ﹤0.01% |
+25,000
| New | +$3.45M |
|
2925
Vanguard High Dividend Yield ETF
VYM
$82.8B
| $3.51M | ﹤0.01% |
+33,057
| New | +$3.47M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.